Novartis AG
Antiviral Pyrazolopyridinone Compounds
Last updated:
Abstract:
The invention provides compounds of Formula (I) ##STR00001## as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by herpesviruses.
Status:
Application
Type:
Utility
Filling date:
24 Sep 2020
Issue date:
6 May 2021